With over 2,700 products in 85 countries and 1000 employees, DEMO is active in the development, production and trade of pharmaceutical products. Its new investment plan 2021-2027, worth 356 million euros, includes the production of raw materials, the expansion of the production of final products, R&D and biotechnology.

website: demo.gr